A new therapy could prevent lifelong disability for thousands of babies each year, offering hope before birth to families facing spina bifida.

Add Yahoo as a preferred source to see more of our stories on Google. Aspen Neuroscience's autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and "OFF" time in Parkinson's disease patients.